JMS Co Ltd
TSE:7702
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.3), the stock would be worth ¥517.94 (18% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.3 | ¥440 |
0%
|
| 3-Year Average | 0.3 | ¥517.94 |
+18%
|
| 5-Year Average | 0.3 | ¥550.51 |
+25%
|
| Industry Average | 2 | ¥3 351.68 |
+662%
|
| Country Average | 1.4 | ¥2 406.93 |
+447%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
JMS Co Ltd
TSE:7702
|
10.8B JPY | 0.3 | -48.2 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY | 9.6 | 39.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.1B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29B CHF | 1.6 | 36.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
92B DKK | 6.6 | 22.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD | 3.1 | 30.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.2B GBP | 3.7 | 31.8 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.1B CNY | 4.5 | 23.7 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
905.8B JPY | 5.7 | 51.2 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.3T KRW | 19.9 | -37.8 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 0.9 | -15.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.1 |
| Median | 1.4 |
| 70th Percentile | 2.1 |
| Max | 31 732 017.6 |
Other Multiples
JMS Co Ltd
Glance View
JMS Co., Ltd. engages in the manufacture, sale, export, and import of medical devices and pharmaceuticals. The company is headquartered in Hiroshima, Hiroshima-Ken and currently employs 5,604 full-time employees. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The firm operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The firm is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Company’s main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The firm is also involved in the provision of maintenance service and other related services.
